You are correct, biopharm, but another IST report does PPHM no good absent $$$ to fund via outright sale or licensing[field of use at a minimum]. It does provide a list of questions to be proposed for answer by Ronin group and current PPHM crew when opportunity arises:
Citing Literature
Number of times cited: 9
1
Domen Vozel, Bojana Uršic, Judita Lea Krek, Roman Štukelj, Veronika Kralj-Iglic, Applicability of extracellular vesicles in clinical studies, European Journal of Clinical Investigation, 2017, 47, 4, 305
Wiley Online Library
2
Jennifer Oyler-Yaniv, Alon Oyler-Yaniv, Mojdeh Shakiba, Nina K. Min, Ying-Han Chen, Sheue-yann Cheng, Oleg Krichevsky, Nihal Altan-Bonnet, Grégoire Altan-Bonnet, Catch and Release of Cytokines Mediated by Tumor Phosphatidylserine Converts Transient Exposure into Long-Lived Inflammation, Molecular Cell, 2017, 66, 5, 635
CrossRef
3
Christopher D. Gregory, Catriona A. Ford, Jorine J. L. P. Voss, Apoptosis in Cancer Pathogenesis and Anti-cancer Therapy, 2016, 930, 51
CrossRef
4
Ying-Chieh Yang, Chi-Shiun Chiang, Challenges of Using High-Dose Fractionation Radiotherapy in Combination Therapy, Frontiers in Oncology, 2016, 6
CrossRef
5
David E. Gerber, David R. Spigel, David Giorgadze, Mikhail Shtivelband, Olga V. Ponomarova, Joseph S. Shan, Kerstin B. Menander, Chandra P. Belani, Docetaxel Combined With Bavituximab in Previously Treated, Advanced Nonsquamous Non–Small-Cell Lung Cancer, Clinical Lung Cancer, 2016, 17, 3, 169
CrossRef
6
S Nagata, J Suzuki, K Segawa, T Fujii, Exposure of phosphatidylserine on the cell surface, Cell Death and Differentiation, 2016, 23, 6, 952
CrossRef
7
R B Birge, S Boeltz, S Kumar, J Carlson, J Wanderley, D Calianese, M Barcinski, R A Brekken, X Huang, J T Hutchins, B Freimark, C Empig, J Mercer, A J Schroit, G Schett, M Herrmann, Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer, Cell Death and Differentiation, 2016, 23, 6, 962
CrossRef
8
Yu-Ting Cheng, Chun-Chih Yang, Lie-Fen Shyur, Phytomedicine—Modulating oxidative stress and the tumor microenvironment for cancer therapy, Pharmacological Research, 2016, 114, 128
CrossRef
9
A A Baxter, M D Hulett, I KH Poon, The phospholipid code: a key component of dying cell recognition, tumor progression and host–microbe interactions, Cell Death and Differentiation, 2015, 22, 12, 1893
